We've launched our new Cancer Innovation Strategy 2025 - 2028!
In partnership with Health Innovation West of England, our strategy sets out our vision to improve cancer outcomes, earlier diagnosis and more personalised treatment.
The Somerset, Wiltshire, Avon & Gloucestershire Cancer Alliance is the forum to bring providers and commissioners together with patients, to co-design services to optimise pathways, ensure effective integration and address variation, and are the vehicle that leads the activity required at a local level to meet the ambitions set out by the National Cancer Programme Team.
The Cancer Alliance puts clinical leaders across primary, secondary, and tertiary care in the driving seat for improving quality and outcomes across cancer pathways, based on shared data and metrics. Continuing to deliver the strategy and its programmes will require committed leadership, smart choices around investing to save, and a firm intent to try new approaches and test new models of care.
About SWAG Cancer Alliance
We are responsible for leading the local delivery of the national cancer strategy which sets an exciting vision for the transformation of cancer services.
Our Priorities
Early Diagnosis
Early Diagnosis
Faster Diagnosis
Faster Diagnosis
Innovation and Research
Innovation & Research
Treatment and Care
Treatment and Care
Health Inequalities
Health Inequalities
Patient Engagement
Patient Engagement
Latest news
Liver Cancer Awareness Month: Catching Liver Disease Early Saves Lives
Primary Liver cancer is one of the fastest-rising causes of cancer death in the UK. Yet, it often goes undetected until it’s too late. At Somerset Wiltshire Avon & Gloucestershire…
New partnership launched to reduce inequalities in access to cancer care
A new partnership has launched which aims to uncover inequalities and barriers to accessing cancer care and shape how services can be improved for the most vulnerable people in Somerset,…
New small grants scheme launched to tackle health inequalities across SWAG
Cancer remains one of the leading causes of death in the UK, with nearly 3.5 million people currently living with the disease. While progress has been made in early diagnosis,…



